Open AccessRandomized controlled trial of the significance of combined use with Ninjin’yoeito in CapeOX + Bmab therapy for patients with unresectable advanced/recurrent colorectal cancer
Author(s) -
Yoshiharu Motoo,
Kazuo Shinozaki,
Tsuyoshi Takagi,
Shingo Ito,
Hideto Fujita,
Yoshinori Munemoto,
Naohisa Yoshida,
Eishi Baba,
Yoshitaro Shindo,
Takamasa Nishiuchi,
Masatomo Miura,
Satoshi Morita,
Akihito Tsuji
Publication year - 2022
Publication title -
medicine, case reports and study protocols
Language(s) - English
Resource type - Journals
ISSN - 2691-3895
DOI - 10.1097/md9.0000000000000196
Subject(s) - medicine , capecitabine , oxaliplatin , bevacizumab , colorectal cancer , adverse effect , oncology , cancer , common terminology criteria for adverse events , chemotherapy